In this report, we utilized a well-characterized preclinical mouse model of MPS II treated with a novel brain Enzyme Transport Vehicle:Iduronate-2-sulfatase fusion protein (ETV:IDS) [31] to investigate the relationship between brain and CSF GAGs and downstream biomarkers of disease such as Nf-L. The gene discussed is IDS; the disease is mucopolysaccharidosis type 2.